Drug Research
CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited CAR-NK celltherapy
CytoviaTherapeutics,a biopharmaceutical company, and the University of California,San Francisco(UCSF) announced that they have entered a 3-year research partnership to develop novel precision gene editing to improve the performance, safety and persistence of Natural Killer(NK) cells and Chimeric Antigen Receptor(CAR)-NK...
Press Releases
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China. This significant milestone marks WuXi STA’s establishment of a comprehensive...
Drug Research
Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology drug discovery
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia’s proprietary AI drug discovery platform and drug design know-how with...
Press Releases
Mundipharma enters partnership with Samsung Bioepis to expand biosimilars into Hong Kong and Taiwan
Mundipharma announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong.
The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab),...
Drug Research
Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic and Inflammatory Diseases
The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore clinicians, clinician scientists and scientists from National Heart Centre Singapore (NHCS), SingHealth Duke-NUS AMC and the Singapore based biotech company Enleofen Bio, along with...
Press Releases
BioAsia to promote innovations in Life Science and Healthcare through Start-up Stage in its 17th Edition
Asia's largest Life-sciences and healthcare forum BioAsia, will continue to feature a dedicated platform - Start-up Stage in its 17th edition to be held at Hyderabad between February 17th to 19th February 2020. The Start-up Stage at BioAsia 2020...
Clinical Trials
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
Signant Health announced a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma and COPD (chronic obstructive pulmonary disease).
The partnership will help drive patient adherence to inhaled medications...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read